New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer
- PMID: 22098273
- PMCID: PMC3665011
- DOI: 10.1080/01635581.2012.630158
New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer
Abstract
Prostate cancer is the most commonly diagnosed cancer and second most common cause of cancer deaths in American men. Its long latency, slow progression, and high incidence rate make prostate cancer ideal for targeted chemopreventative therapies. Therefore, chemoprevention studies and clinical trials are essential for reducing the burden of prostate cancer on society. Epidemiological studies suggest that tea consumption has protective effects against a variety of human cancers, including that of the prostate. Laboratory and clinical studies have demonstrated that green tea components, specifically the green tea catechin (GTC) epigallocatechin gallate, can induce apoptosis, suppress progression, and inhibit invasion and metastasis of prostate cancer. Multiple mechanisms are involved in the chemoprevention of prostate cancer with GTCs; understanding and refining models of fundamental molecular pathways by which GTCs modulate prostate carcinogenesis is essential to apply the utilization of green tea for the chemoprevention of prostate cancer in clinical settings. The objective of this article is to review and summarize the most current literature focusing on the major mechanisms of GTC chemopreventative action on prostate cancer from laboratory, in vitro, and in vivo studies, and clinical chemoprevention trials.
Figures
![FIG. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3665011/bin/nihms451958f1.gif)
Similar articles
-
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.Nutr Cancer. 2009;61(6):836-41. doi: 10.1080/01635580903285056. Nutr Cancer. 2009. PMID: 20155624 Free PMC article. Review.
-
Green tea and prostate cancer: from bench to clinic.Front Biosci (Elite Ed). 2009 Jun 1;1(1):13-25. doi: 10.2741/E2. Front Biosci (Elite Ed). 2009. PMID: 19482620 Free PMC article. Review.
-
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.Carcinogenesis. 2004 Nov;25(11):2217-24. doi: 10.1093/carcin/bgh235. Epub 2004 Sep 9. Carcinogenesis. 2004. PMID: 15358631
-
Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells.Life Sci. 2001 Jan 26;68(10):1207-14. doi: 10.1016/s0024-3205(00)01020-1. Life Sci. 2001. PMID: 11228105
-
Prostate cancer chemoprevention by green tea.Semin Urol Oncol. 1999 May;17(2):70-6. Semin Urol Oncol. 1999. PMID: 10332919 Review.
Cited by
-
Epigallocatechin-3-gallate and its nanoformulation in cervical cancer therapy: the role of genes, MicroRNA and DNA methylation patterns.Cancer Cell Int. 2023 Dec 21;23(1):335. doi: 10.1186/s12935-023-03161-9. Cancer Cell Int. 2023. PMID: 38129839 Free PMC article. Review.
-
Novel Insights into the Role of the Antioxidants in Prostate Pathology.Antioxidants (Basel). 2023 Jan 27;12(2):289. doi: 10.3390/antiox12020289. Antioxidants (Basel). 2023. PMID: 36829848 Free PMC article. Review.
-
Green Tea in Reproductive Cancers: Could Treatment Be as Simple?Cancers (Basel). 2023 Jan 30;15(3):862. doi: 10.3390/cancers15030862. Cancers (Basel). 2023. PMID: 36765820 Free PMC article. Review.
-
Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome.Cancers (Basel). 2022 Aug 18;14(16):3988. doi: 10.3390/cancers14163988. Cancers (Basel). 2022. PMID: 36010981 Free PMC article. Review.
-
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.EPMA J. 2022 Jul 8;13(3):461-486. doi: 10.1007/s13167-022-00288-z. eCollection 2022 Sep. EPMA J. 2022. PMID: 35821883 Free PMC article. Review.
References
-
- American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society; 2010.
-
- Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17:360–379. - PubMed
-
- Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol. 2006;175:820–834. - PubMed
-
- Kraft A, Weindel K, Ochs A, Marth C, Zmija J, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer. 1999;85:178–187. - PubMed
-
- Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, et al. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int. 2007;99:908–915. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical